Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease

Completed · Phase 2

Conditions studied: Gaucher's Disease, Osteopenia

In brief

OBJECTIVES: I. Determine the efficacy of alendronate sodium in treating osteopenia (generalized bone density and focal bone lesions) in patients with Gaucher's disease.

Key facts

Study ID

NCT00004488

Run by

Children's Hospital Medical Center, Cincinnati

People needed

82

Starts

1998-10-01

Expected to finish

2002-09-01

Last updated by the study team

2015-03-25

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Children's Hospital Medical Center - Cincinnati — Cincinnati, Ohio, United States
• Wright State University School of Medicine — Dayton, Ohio, United States
• Shaare Zedek Medical Center — Jerusalem, Israel

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.